Infections and endothelial cells

被引:83
作者
Keller, TT
Mairuhu, ATA
de Kruif, MD
Klein, SK
Gerdes, VEA
ten Cate, H
Brandjes, DPM
Levi, M
van Gorp, ECM
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Lab Expt Internal Med, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands
[4] Slotervaart Hosp, Dept Internal Med, NL-1066 EC Amsterdam, Netherlands
[5] Acad Hosp Maastricht, Dept Internal Med, NL-6229 HX Maastricht, Netherlands
关键词
endothelium; infection; coagulation; atherosclerosis; protein C;
D O I
10.1016/S0008-6363(03)00354-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic infection by various pathogens interacts with the endothelium and may result in altered coagulation, vasculitis and atherosclerosis. Endothelium plays a role in the initiation and regulation of both coagulation and fibrinolysis. Exposure of endothelial cells may lead to rapid activation of coagulation via tissue factor (TF) expression and the loss of anticoagulant properties by impairment of antithrombin III, TF pathway inhibitor (TFPI) and the protein C system. Endothelial-derived plasminogen activator inhibitor (PAI) is essential for the regulation of fibrinolysis and impaired endothelial function leads to imbalance in fibrinolysis, resulting in a procoagulant state. The interaction between inflammation and coagulation, soluble adhesion molecules and circulation endothelial cells is important in the pathogenesis of an unbalanced haemostatic system. Rather than being a unidirectional relationship, the interaction between inflammation and coagulation appears to be significant. In the crosstalk, the endothelium is playing a pivotal role. (C) 2003 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:40 / 48
页数:9
相关论文
共 102 条
[1]   Vascular bed-specific hemostasis: Role of endothelium in pathogenesis [J].
Aird, WC .
CRITICAL CARE MEDICINE, 2001, 29 (07) :S28-S34
[2]   LIPID-COMPOSITION AND FLUIDITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE AND HOST-CELL PLASMA-MEMBRANES [J].
ALOIA, RC ;
TIAN, HR ;
JENSEN, FC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (11) :5181-5185
[3]   Bacterial lipopolysaccharide disrupts endothelial monolayer integrity and survival signaling events through caspase cleavage of adherens junction proteins [J].
Bannerman, DD ;
Sathyamoorthy, M ;
Goldblum, SE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (52) :35371-35380
[4]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[5]  
Bhagat K, 1996, CARDIOVASC RES, V32, P822
[6]   PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 RELEASE DURING EXPERIMENTAL ENDOTOXEMIA IN CHIMPANZEES - EFFECT OF INTERVENTIONS IN THE CYTOKINE AND COAGULATION CASCADES [J].
BIEMOND, BJ ;
LEVI, M ;
TENCATE, H ;
VANDERPOLL, T ;
BULLER, HR ;
HACK, CE ;
TENCATE, JW .
CLINICAL SCIENCE, 1995, 88 (05) :587-594
[7]   Von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia [J].
Blann, AD ;
Miller, JP ;
McCollum, CN .
ATHEROSCLEROSIS, 1997, 132 (02) :151-156
[8]  
Blann AD, 1997, EUR J HAEMATOL, V59, P115
[9]   Soluble platelet endothelial cell adhesion molecule-1 (sPECAM-1) in inflammatory vascular disease, atherosclerotic vascular disease, and in cancer [J].
Blann, AD ;
Wadley, MS ;
Dobrotova, M ;
Sanders, P ;
Jayson, MIV ;
McCollum, CN .
BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (01) :99-103
[10]  
BOERMEESTER MA, 1995, ARCH SURG-CHICAGO, V130, P739